Qi Yi Luo
Director/Board Member chez MICROPORT SCIENTIFIC CORPORATION
Fortune : 5 M $ au 31/03/2024
Profil
Actuellement, Qi Yi Luo occupe le poste de président non exécutif de MicroPort CardioFlow Medtech Corp. et de directeur de la technologie de MicroPort Scientific Corp. et de président de Shanghai MicroPort CardioFlow Medtech Co., Ltd. (une filiale de MicroPort Scientific Corp.). M. Luo siège également au conseil d'administration de Shanghai MicroPort EP MedTech Co., Ltd. M. Luo a obtenu un diplôme d'études supérieures de l'université Queen's, un diplôme de premier cycle de l'université technologique et commerciale de Yunnan et un doctorat de l'université des sciences et technologies de Shanghai.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/08/2023 | 6 503 897 ( 0,35% ) | 5 M $ | 31/03/2024 |
Postes actifs de Qi Yi Luo
| Sociétés | Poste | Début |
|---|---|---|
| MICROPORT SCIENTIFIC CORPORATION | Director/Board Member | 30/08/2023 |
MicroPort Cardiac Rhythm Management International Ltd.
 MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Director/Board Member | 28/04/2020 |
Anciens postes connus de Qi Yi Luo
| Sociétés | Poste | Fin |
|---|---|---|
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Director/Board Member | 15/09/2023 |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Chairman | 29/08/2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Chairman | 29/08/2023 |
Vas-Cath, Inc.
 Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Director/Board Member | 01/01/1995 |
Formation de Qi Yi Luo
| Queen's University | Graduate Degree |
| Yunnan Technology & Business University | Undergraduate Degree |
| University of Shanghai for Science & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MICROPORT SCIENTIFIC CORPORATION | Health Technology |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |
